TNFRSF13B and agammaglobulinemia: Although studies have shown that mutations of the TNFRSF13B gene (encoding TACI) are reported in about 10% of CVID patients, these mutations have also been observed in healthy people without hypogammaglobulinemia, challenging their pathologic impact and suggesting the involvement of genetic modifiers and environmental agents [7].